Gamma knife radiosurgery is a radiation type of therapy used to treat tumors, vascular malformations, and other abnormalities in the brain. Gamma knife radiosurgery is different from other forms of stereotactic radiosurgery (SRS), as in gamma knife surgery there is no incision. Moreover, gamma knife radiosurgery uses specialized equipment to focus about 200 tiny beams of radiation on a tumor or other target with submillimeter accuracy. A strong dose of radiation is delivered to the place where all the beams meet, as compared to effect of each beam. The precision of brain stereotactic radiosurgery results in minimal radiation delivery to healthy tissues surrounding the target. This type of radiation treatment is usually performed, if a person is suffering from a tumor or other abnormality in the brain that is difficult to reach with standard neurosurgery, or a person is not healthy enough to undergo standard surgery, and if a person prefers a less invasive treatment.
Market Dynamics
Increasing collaboration between major players is expected to drive the global gamma knife market. For instance, in March 2020, Elekta and San Jose Moscati Hospital teamed up to equip new center in Queretaro State with comprehensive range of radiotherapy solutions, to treat cancer patients in Mexico. The agreement comprises a broad array of cancer treatment and radiotherapy support systems such as Elekta Unity, Leksell Gamma Knife, and brachytherapy using Flexitron, Versa HD linear accelerator, and MOSAIQ oncology information system.
However, growth of the global gamma knife market is expected to be hampered over the forecast period, owing to increasing FDA recalls. For instance, in May 2017, the U.S. Food and Drug Administration recalled the Leksell Gamma Knife Icon developed by Elekta, Inc., under Class 2 Device Recall due to safety issues.
Key features of the study:
- This report provides in-depth analysis of the global gamma knife market size (US$), and compound annual growth rate (CAGR) for the forecast period: 2020-2027, considering 2019 as the base year.
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players.
- It profiles key players in the global gamma knife market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include Elekta AB, American Radiosurgery inc., and Masep Medical Science & Technology Development Co., Ltd.
- Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global gamma knife market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for dialysis market, research and consulting firms, new entrants, and financial analysts.
Detailed Segmentation:
- Global Gamma Knife Market, By Indication:
- Brain Metastasis
- Arteriovenous Malformation (AVM)
- Trigeminal Neuralgia
- Others
- Global Gamma Knife Market, By Anatomy:
- Global Gamma Knife Market, By End User:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Global Gamma Knife Market, By Region:
- North America
- By Country:
- By Indication
- Brain Metastasis
- Arteriovenous Malformation (AVM)
- Trigeminal Neuralgia
- Others
- By Anatomy
- By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Europe
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- By Indication
- Brain Metastasis
- Arteriovenous Malformation (AVM)
- Trigeminal Neuralgia
- Others
- By Anatomy
- By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- By Indication
- Brain Metastasis
- Arteriovenous Malformation (AVM)
- Trigeminal Neuralgia
- Others
- By Anatomy
- By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Indication
- Brain Metastasis
- Arteriovenous Malformation (AVM)
- Trigeminal Neuralgia
- Others
- By Anatomy
- By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Indication
- Brain Metastasis
- Arteriovenous Malformation (AVM)
- Trigeminal Neuralgia
- Others
- By Anatomy
- By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Indication
- Brain Metastasis
- Arteriovenous Malformation (AVM)
- Trigeminal Neuralgia
- Others
- By Anatomy
- By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Company Profiles
- Elekta AB*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- American Radiosurgery Inc.
- Masep Medical Science & Technology Development Co., Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
